跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EPINEPHRINE INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
EPINEPHRINE INJECTION
Authorized
STANDARD
EPINEPHRINE INJECTION
Laboratoire Aguettant
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
fdcfd4a9c4e57cc1
Company
Laboratoire Aguettant
Type
Standard
Approval Details
Approval Id
fdcfd4a9c4e57cc1
Drug Approval Canada Name
EPINEPHRINE INJECTION
Product Name
EPINEPHRINE INJECTION
Status
Marketed
Status Date
2022-05-18
Original Market Date
2022-05-18
Din
02521148
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
12:12.12
Atc Original
C01CA24 EPINEPHRINE
Atc Name
c 01 ca 24
Aig Number
0104871003
Company Name
Laboratoire Aguettant
Company Address
1, Rue Alexander Fleming, Lyon, Rhône, France, 69007
Company Detail Path
/organization/laboratoire-aguettant
Company Information
Pharmaceutical Company Name
Laboratoire Aguettant
Country Name
Belgium
City Name
unknown,country_be
Address
Unknown Belgian address
Website
https://www.aguettant.co.uk
Active Ingredients
EPINEPHRINE (EPINEPHRINE BITARTRATE)
1 MG / 10 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
fdcfd4a9c4e57cc1
Type
Standard
Back to Health Canada Approvals